Patrick Flatley
About Patrick Flatley
Patrick Flatley is the Senior Manager of Manufacturing Technology at Bristol Myers Squibb, specializing in scaling products and operations globally in biotech, pharma, and specialty chemicals.
Current Position at Bristol Myers Squibb
Patrick Flatley currently serves as the Senior Manager of Manufacturing Technology at Bristol Myers Squibb in Massachusetts, United States. In this role, he is responsible for scaling products and operations globally in the biotech and pharmaceutical sectors, focusing on both quality and efficiency.
Previous Experience in Manufacturing Technology
From 2020 to 2022, Patrick Flatley held the position of Manager, Senior Manufacturing Engineer at Bristol Myers Squibb in Devens, Massachusetts. He played a key role in leading two successful PPQ campaigns and BLA filings, significantly accelerating processes by more than 60% compared to industry standards. Prior to this, he worked at Repligen Corporation from 2014 to 2020, where he amassed experience as a Manufacturing Process Engineer, Quality Engineer, and Quality Associate in Technical Operations. His career began at SeraCare Life Sciences as a Manufacturing Associate in 2013.
Educational Background in Engineering and Business
Patrick Flatley is currently pursuing an Executive MBA in Business Administration and Management, General at The University of Chicago Booth School of Business, with completion anticipated in 2025. He earned a Master of Science (M.S.) in Chemical Engineering from the University of Massachusetts Lowell from 2016 to 2019. In 2015, he completed a Graduate Certificate in Chemical Engineering at Michigan State University. His academic foundation was laid at the University of New England, where he achieved a Bachelor of Science (BS) in Biochemistry from 2009 to 2013.
Key Achievements in Process Optimization
Patrick Flatley has a proven track record in process optimization, notably boosting launch facility production output by an impressive 453% through effective cross-functional matrixed leadership. He also developed and implemented a pipeline commercialization strategy for three leading molecules, aiming to reduce time-to-market by up to 40%. His expertise includes innovating in regulatory markets and defining unknown problems to create scalable and repeatable production programs.
Specialization in Biotech and Pharmaceutical Industry
With a specialization in biotech, pharma, and specialty chemicals, Patrick Flatley excels in scaling products and operations globally. He is recognized for fostering a patient-centric culture and driving a quality-oriented approach. His leadership focuses on developing high-performing teams and maintaining a strong emphasis on efficiency and innovation in manufacturing technology.